Management of Dominant Optic Atrophy: Supportive Approach and Protective Measures

Dominant optic atrophy (DOA) is a hereditary optic nerve condition causing progressive visual impairment. Because no preventative or curative therapy currently exists, clinical management centres on supportive strategies and prophylactic steps to preserve remaining visual function.

Clinical approach

Patients with significantly reduced visual acuity may benefit from low-vision aids as a supportive measure. Alongside this, certain lifestyle and pharmacological avoidances are recommended as prophylactic steps — the full structured protocol details which specific agents and behaviours are relevant and why.

The complete evidence-based regimen — including specific prophylactic guidance and clinical decision points — is available via the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1186/1750-1172-7-46

To date, there is no preventative or curative treatment in DOA; severely visually impaired patients may benefit from low vision aids.

To date, no specific treatment exists, but low-vision aids in patients with severely decreased visual acuity can be beneficial.

Avoiding tobacco and alcohol intake as well as medications (antibiotics, antivirals) which can interfere with mitochondrial metabolism can be additional prophylactic measures.

View source ↗